WHWK Whitehawk Therapeutics, Inc. - Common Stock
$4,88
Prix · Aoû 19, 2026
Données fondamentales au Aoû 6, 2026
Fourchette 52 semaines
$2–$5
84% of range
Note des analystes
BUY
14 analysts
Objectif de cours
$8
+54% upside
P/E (TTM)
-14.8
ROE
-13.4%
Marge nette
-288.3%
WHWK Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$4.88
Capitalisation Boursière
$230M
P/E (TTM)
-14.8
BPA (TTM)
$-0.33
Revenus (TTM)
$7M
Rendement div.
—
ROE
-13.4%
Dette/Capitaux propres
—
Fourchette 52 semaines
$2 – $5
WHWK Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$7M
2018-12-31
→
2025-12-31
BPA
$-0.33
2021-12-31
→
2025-12-31
Flux de trésorerie libre
$-98M
2018-12-31
→
2025-12-31
Marges
-288.3%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
WHWK
Médiane des pairs
P/E (TTM)
-14.8
1.2
P/S (TTM)
32.2
6.3
P/B
1.7
1.6
Price / FCF (Cours / FCF)
-2.4
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
WHWK
Médiane des pairs
Operating Margin (Marge d'exploitation)
-1601.1%
—
Net Profit Margin (Marge nette)
-288.3%
-312.6%
ROA
-18.6%
-56.8%
ROE
-13.4%
-83.3%
ROIC
-83.9%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
WHWK
Médiane des pairs
Current Ratio (Ratio de liquidité)
10.3
8.5
Quick Ratio (Ratio de liquidité réduite)
10.0
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
WHWK
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
-72.5%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
-22.3%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
-12.6%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
WHWK
Médiane des pairs
WHWK Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
14 analystes
- Achat fort 4 28,6%
- Achat 6 42,9%
- Conserver 4 28,6%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
6 analystes · 2026-08-15
Médiane
$7.50
Maintenant
$4.88
Bas
$4.00
Haut
$10.00
Objectif médian
$7.50
+53,7%
Objectif moyen
$7.50
+53,7%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-0.25%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.20 | $-0.30 | 0.10% |
| 31 mars 2026 | $-0.32 | $-0.36 | 0.04% |
| 31 décembre 2025 | $-0.34 | $-0.16 | -0.18% |
| 30 septembre 2025 | $-0.26 | $0.07 | -0.33% |
| 30 juin 2025 | $-0.76 | $0.50 | -1.3% |
| 31 mars 2025 | $-0.37 | $-0.47 | 0.10% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| PEPG | $448M | -3.1 | — | — | -82.0% | — |
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| CRBP | $143M | -1.4 | — | — | -60.8% | — |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | — |
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Cost of Revenue | $760.0K | $3M | $3M | $1M | $0 | · | · | · | |
| R&D Expense | $91M | $51M | $49M | $33M | $20M | $15M | $13M | $18M | |
| SG&A Expense | $30M | $37M | $45M | $40M | $19M | $2M | $10M | $13M | |
| Operating Expenses | $122M | $93M | $96M | $78M | $112M | $17M | $24M | $31M | |
| Operating Income | $-114M | $-67M | $-72M | $-63M | $-111M | $-3M | $-24M | $-11M | |
| Interest Expense | · | · | $231.0K | $230.0K | $665.0K | $815.0K | · | · | |
| Interest Income | $6M | $4M | $6M | $2M | $13.0K | $41.0K | · | · | |
| Other Non-op | $94M | $4M | $6M | $2M | $1M | $-927.0K | $1M | $784.6K | |
| Pretax Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $2.0K | $2.0K | · | · | |
| Net Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| EPS (Basic) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| EPS (Diluted) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| Shares (Basic) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| Shares (Diluted) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| EBITDA | $-114M | $-67M | $-72M | $-63M | $-111M | $-6M | $-24M | $-11M |
Bilan 25
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $29M | $63M | $39M | $149M | $4M | $39M | $63M | |
| Short-term Investments | $108M | $19M | $46M | $134M | $0 | · | · | · | |
| Receivables | $0 | $6M | $5M | $2M | $0 | $14M | · | · | |
| Inventory | $0 | $5M | $6M | $2M | $0 | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $4M | $2M | $81.0K | $311.2K | $754.4K | |
| Other Current Assets | · | · | · | · | · | $2M | $734.8K | $615.7K | |
| Current Assets | $149M | $61M | $125M | $180M | $151M | $19M | $40M | $64M | |
| PP&E (Net) | $3.0K | $7M | $5M | $508.0K | $57.0K | $21.0K | $164.2K | $98.4K | |
| PP&E (Gross) | $377.0K | $7M | $5M | $609.0K | $87.0K | $512.1K | $493.0K | $409.6K | |
| Accum. Depreciation | $374.0K | $463.0K | $270.0K | $101.0K | $30.0K | $390.3K | $328.9K | $311.1K | |
| Intangibles | · | · | · | $0 | $4M | · | · | · | |
| Other Non-current Assets | $2M | $1M | $2M | $2M | $2M | · | · | · | |
| Total Assets | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Accounts Payable | $917.0K | $2M | $6M | $4M | $6M | $2M | $439.8K | $595.7K | |
| Accrued Liabilities | $14M | $15M | $14M | $15M | $9M | $4M | · | · | |
| Current Liabilities | $15M | $17M | $26M | $19M | $15M | $30M | $3M | $5M | |
| Capital Leases | $0 | $565.0K | $833.0K | $1M | $474.0K | · | $67.4K | · | |
| Other Non-current Liabilities | $0 | $202.0K | $0 | · | $0 | $97.0K | · | · | |
| Total Liabilities | $15M | $18M | $27M | $26M | $22M | $31M | $3M | $5M | |
| Common Stock | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $4.1K | $4.1K | |
| Retained Earnings | $-353M | $-333M | $-269M | $-203M | $-143M | $-33M | $-142M | $-119M | |
| AOCI | $120.0K | $16.0K | $27.0K | $-115.0K | $0 | · | · | · | |
| Stockholders' Equity | $136M | $52M | $105M | $158M | $136M | $-12M | $-9M | $59M | |
| Liabilities + Equity | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Shares Outstanding | 47,145,719 | 24,681,000 | 24,554,000 | 24,435,000 | 20,895,000 | 2,542,358 | 40,588,004 | 40,588,004 |
Flux de trésorerie 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $79.0K | $193.0K | $169.0K | $159.0K | $105.0K | $9.0K | · | · | |
| Stock-based Comp | $10M | $11M | $12M | $10M | $2M | $139.0K | $1M | $3M | |
| Deferred Tax | · | · | · | · | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | · | · | $0 | $87.0K | $95.0K | $0 | · | · | |
| Restructuring | $0 | $3M | $0 | · | · | · | · | · | |
| Other Non-cash | $-87M | $-7M | $-6M | $1M | $85M | · | · | · | |
| Operating Cash Flow | $-97M | $-60M | $-60M | $-50M | $-22M | $-13M | $-24M | $-6M | |
| CapEx | $552.0K | $2M | $4M | $444.0K | $46.0K | $19.0K | $237.0K | $37.9K | |
| Investing Cash Flow | $12M | $25M | $83M | $-133M | $25M | $-19.0K | $-237.0K | $-37.9K | |
| Stock Issued | · | · | · | $0 | $155M | $10M | · | $52M | |
| Net Stock Activity | · | · | · | $0 | $155M | $10M | · | $52M | |
| Dividends Paid | · | · | · | $0 | $4M | · | · | · | |
| Financing Cash Flow | $94M | $130.0K | $326.0K | $73M | $142M | $1M | · | $48M | |
| Net Change in Cash | $9M | $-34M | $24M | $-110M | $145M | $-12M | $-24M | $42M | |
| Free Cash Flow | $-98M | $-61M | $-64M | $-50M | $-22M | $-5M | $-24M | $-6M | |
| Levered FCF | · | · | $-64M | $-50M | $-23M | · | · | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% | -42.4% | · | -55.5% | |
| Net Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.5% | -28.8% | · | -51.6% | |
| Pretax Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.3% | · | · | · | |
| EBITDA Margin | -1600.0% | -258.9% | -294.7% | -410.9% | -9920.7% | -42.4% | · | -55.5% | |
| ROA | -18.6% | -62.8% | -41.5% | -35.4% | -124.6% | -10.2% | -44.7% | -24.4% | |
| ROE | -13.4% | -105.0% | -58.9% | -37.0% | -76.6% | -38.2% | -59.5% | -16.6% | |
| ROIC | -83.9% | -128.6% | -68.4% | -39.6% | -81.5% | · | · | · |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 | 24.0 | 11.9 | 11.7 | |
| Quick Ratio | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 | 22.8 | 11.6 | 11.5 | |
| Interest Coverage | · | · | -311.4 | -272.5 | -167.2 | · | · | · |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.3 | 0.2 | 0.1 | 0.0 | 0.4 | · | 0.5 | |
| Inventory Turnover | 0.3 | 0.5 | 0.7 | 1.4 | · | · | · | · | |
| Receivables Turnover | 2.4 | 4.6 | 6.6 | 16.3 | · | · | · | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -72.5% | 6.7% | 60.1% | 8.7% | 0.00% | · | · | · | |
| Revenue CAGR 3Y | -22.3% | 22.9% | 20.3% | · | · | · | · | · | |
| Revenue CAGR 5Y | -12.6% | · | · | · | · | · | · | · |
Valorisation (TTM) 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Net Income TTM | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| Market Cap | $114M | $78M | $50M | $314M | $505M | $695M | $380M | $1.03B | |
| P/E | -7.3 | -1.3 | -0.8 | -4.8 | -1.9 | · | · | · | |
| P/S | 16.0 | 3.0 | 2.0 | 20.6 | 36.0 | 49.6 | · | 51.3 | |
| P/B | 0.8 | 1.5 | 0.5 | 2.0 | 3.7 | 16.1 | 10.4 | 17.6 | |
| P / Tangible Book | 0.8 | 1.5 | 0.5 | 2.0 | 3.8 | · | · | · | |
| P / Cash Flow | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -129.0 | -15.9 | -178.2 | |
| P / FCF | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -128.5 | -15.8 | -177.0 | |
| Dividend Yield | · | · | · | 0.00% | 0.87% | · | · | · | |
| Earnings Yield | -13.6% | -74.8% | -120.8% | -21.0% | -51.4% | · | · | · | |
| Payout Ratio | · | · | · | 0.00% | -4.0% | · | · | · | |
| Annual Payout | · | · | · | $0 | $4M | · | · | · |
Compte de résultat 17
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $6M | $5M | $6M | $6M | $6M | $6M | $5M | $4M | |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $760.0K | $790.0K | $804.0K | $778.0K | $652.0K | $927.0K | $697.0K | $656.0K | $529.0K | $222.0K | $593.0K | |
| R&D Expense | $13M | $17M | $19M | $14M | $49M | $9M | $14M | $10M | $13M | $14M | $13M | $12M | $13M | $11M | $9M | $9M | |
| SG&A Expense | $5M | $6M | $6M | $5M | $6M | $13M | $11M | $7M | $8M | $11M | $10M | $11M | $12M | $11M | $11M | $10M | |
| Operating Expenses | $18M | $24M | $25M | $20M | $55M | $22M | $26M | $21M | $22M | $25M | $24M | $24M | $26M | $23M | $21M | $19M | |
| Operating Income | $-18M | $-24M | $-25M | $-20M | $-55M | $-15M | $-19M | $-13M | $-16M | $-20M | $-18M | $-18M | $-20M | $-17M | $-15M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $58.0K | · | $58.0K | $58.0K | $58.0K | $56.0K | $58.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $791.0K | $676.0K | $906.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $620.0K | |
| Other Non-op | $1M | $1M | $2M | $2M | $2M | $88M | $676.0K | $867.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $562.0K | |
| Pretax Income | $-17M | $-22M | · | · | $-53M | $73M | · | · | · | · | $-16M | $-16M | $-18M | · | $-14M | $-14M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-9.0K | $0 | |
| Net Income | $-17M | $-22M | $-23M | $-18M | $-53M | $73M | $-18M | $-13M | $-15M | $-18M | $-16M | $-16M | $-18M | $-15M | $-14M | $-14M | |
| EPS (Basic) | $-0.20 | $-0.32 | $-1.15 | $-0.26 | $-0.76 | $1.84 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| EPS (Diluted) | $-0.20 | $-0.32 | $-1.14 | $-0.26 | $-0.76 | $1.83 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| Shares (Basic) | 82,886,196 | 69,236,945 | -116,042,087 | 69,204,899 | 69,083,127 | 39,640,826 | -54,002,096 | 27,041,327 | 27,010,013 | 26,980,698 | -53,770,451 | 26,946,683 | 26,879,089 | 26,862,646 | -40,643,227 | 21,269,163 | |
| Shares (Diluted) | 82,886,196 | 69,236,945 | -116,333,800 | 69,204,899 | 69,083,127 | 39,932,539 | -54,002,096 | 27,041,327 | 27,010,013 | 26,980,698 | -53,770,451 | 26,946,683 | 26,879,089 | 26,862,646 | -40,643,227 | 21,269,163 | |
| EBITDA | $-18M | $-24M | · | $-20M | $-55M | $-15M | · | $-13M | $-16M | $-19M | · | $-18M | $-20M | $-17M | · | $-15M |
Bilan 24
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $35M | $38M | $38M | $145M | $228M | $29M | $31M | $41M | $54M | $63M | $69M | $68M | $34M | $39M | $135M | |
| Short-term Investments | $105M | $88M | $108M | $125M | $32M | $3M | $19M | $32M | $37M | $34M | $46M | $51M | $67M | $117M | $134M | $48M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $6M | $7M | $6M | $5M | $5M | $6M | $4M | $6M | $2M | $2M | |
| Inventory | · | · | $0 | $0 | $0 | $0 | $5M | $5M | $6M | $6M | $6M | $4M | $3M | $4M | $2M | $734.0K | |
| Prepaid Expense | $2M | $3M | $3M | $2M | $1M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | |
| Current Assets | $192M | $126M | $149M | $165M | $179M | $233M | $61M | $77M | $93M | $103M | $125M | $133M | $145M | $165M | $180M | $190M | |
| PP&E (Net) | $1.0K | $2.0K | $3.0K | $4.0K | $9.0K | $25.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $508.0K | $457.0K | |
| PP&E (Gross) | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $609.0K | · | |
| Accum. Depreciation | $376.0K | $375.0K | $374.0K | $373.0K | $368.0K | $352.0K | $463.0K | $416.0K | $369.0K | $320.0K | $270.0K | $226.0K | $183.0K | $140.0K | $101.0K | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Accounts Payable | $1M | $2M | $917.0K | $2M | $3M | $4M | $2M | $1M | $2M | $3M | $6M | $3M | $3M | $7M | $4M | $4M | |
| Accrued Liabilities | $10M | $9M | $14M | $8M | $5M | $9M | $15M | $14M | $14M | $11M | $14M | $12M | $10M | $11M | $15M | $14M | |
| Current Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $17M | $16M | $22M | $20M | $26M | $21M | $13M | $18M | $19M | $18M | |
| Capital Leases | · | · | $0 | $0 | $0 | $0 | $565.0K | $624.0K | $682.0K | $738.0K | $833.0K | $946.0K | $1M | $1M | $1M | $1M | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $202.0K | $393.0K | · | · | $0 | · | · | · | · | · | |
| Total Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $18M | $17M | $23M | $21M | $27M | $21M | $20M | $25M | $26M | $25M | |
| Common Stock | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-392M | $-375M | $-353M | $-330M | $-312M | $-260M | $-333M | $-314M | $-302M | $-287M | $-269M | $-253M | $-236M | $-218M | $-203M | $-189M | |
| AOCI | $-63.0K | $-15.0K | $120.0K | $139.0K | $9.0K | $1.0K | $16.0K | $39.0K | $-27.0K | $-8.0K | $27.0K | $-16.0K | $-44.0K | $-32.0K | $-115.0K | $-99.0K | |
| Stockholders' Equity | $183M | $116M | $136M | $157M | $172M | $222M | $52M | $69M | $79M | $90M | $105M | $118M | $131M | $146M | $158M | $169M | |
| Liabilities + Equity | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Shares Outstanding | 57,009,010 | 47,196,564 | 47,145,719 | 47,128,362 | 47,128,362 | 46,784,618 | 24,680,708 | 24,614,834 | 24,614,834 | 24,554,205 | 24,554,205 | 24,525,860 | 24,519,860 | 24,436,990 | 24,435,007 | 24,395,117 |
Flux de trésorerie 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $50.0K | $44.0K | $44.0K | $43.0K | $38.0K | $46.0K | $12.0K | |
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-32.0K | $0 | |
| Restructuring | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | $-9M | · | · | |
| Operating Cash Flow | $-15M | $-22M | $-17M | $-15M | $-53M | $-12M | $-15M | $-16M | $-9M | $-20M | $-10M | $-12M | $-17M | $-21M | $-11M | $-8M | |
| CapEx | $0 | $0 | $0 | $0 | $1.0K | $551.0K | $186.0K | $188.0K | $541.0K | $739.0K | $816.0K | $1M | $689.0K | $1M | $78.0K | $102.0K | |
| Investing Cash Flow | $-17M | $19M | $17M | $-92M | $-29M | $115M | $13M | $5M | $-4M | $11M | $4M | $13M | $51M | $16M | $-84M | $-48M | |
| Financing Cash Flow | $82M | $0 | $25.0K | $0 | $-850.0K | $95M | $53.0K | $0 | $87.0K | $-10.0K | $80.0K | $-75.0K | $313.0K | $8.0K | $-107.0K | $73M | |
| Net Change in Cash | $50M | $-3M | $-363.0K | $-107M | $-83M | $199M | $-2M | $-11M | $-13M | $-9M | $-6M | $641.0K | $34M | $-5M | $-96M | $16M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | |
| Free Cash Flow | · | $-22M | · | · | · | $-12M | · | · | · | $-20M | · | · | · | $-23M | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -364.5% | · | -299.5% | -315.1% | -286.8% | · | -354.2% | |
| Net Margin | · | · | · | · | · | 1021.9% | · | -174.0% | -236.0% | -341.7% | · | -273.6% | -289.8% | -259.5% | · | -341.0% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | -273.6% | -289.8% | · | · | -341.0% | |
| EBITDA Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -363.6% | · | -299.5% | -315.1% | -286.1% | · | -354.2% | |
| ROA | -8.9% | -12.3% | · | -14.0% | -37.3% | 42.3% | · | -11.1% | -11.5% | -13.0% | · | -9.8% | -12.8% | -9.7% | · | -8.0% | |
| ROE | -9.4% | -13.1% | · | -15.7% | -41.9% | 46.8% | · | -13.4% | -13.9% | -15.5% | · | -11.3% | -15.0% | -11.2% | · | -9.0% | |
| ROIC | -9.9% | -20.2% | · | · | · | · | · | · | · | · | · | -15.1% | -14.9% | · | · | -8.9% |
Liquidité et Solvabilité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.4 | 11.4 | · | 16.8 | 20.4 | 19.0 | · | 4.9 | 4.2 | 5.2 | · | 6.5 | 11.2 | 9.3 | · | 10.6 | |
| Quick Ratio | 17.2 | 11.1 | · | 16.5 | 20.2 | 18.8 | · | 4.4 | 3.8 | 4.7 | · | 6.1 | 10.7 | 8.8 | · | 10.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -336.4 | · | -307.7 | -337.0 | -290.1 | · | -259.2 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | 0.0 | 0.0 | 0.3 | · | 0.2 | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.3 | · | 1.6 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 2.9 | · | 1.2 | 1.3 | 1.0 | · | 1.5 | 2.2 | 1.4 | · | 3.7 |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $7M | · | $14M | $21M | $26M | · | $25M | $24M | $23M | · | $22M | $20M | $16M | · | $10M | |
| Net Income TTM | $-109M | $-20M | · | $-10M | $-7M | $28M | · | $-62M | $-67M | $-68M | · | $-64M | $-66M | $-62M | · | $-134M | |
| Market Cap | $261M | $163M | · | $90M | $88M | $83M | · | $51M | $36M | $57M | · | $119M | $168M | $177M | · | $345M | |
| P/E | -3.0 | 7.0 | · | 5.4 | 26.7 | 11.9 | · | -0.9 | -0.6 | -0.9 | · | -1.9 | -2.5 | -2.6 | · | -1.2 | |
| P/S | · | 22.8 | · | 6.2 | 4.3 | 3.2 | · | 2.1 | 1.5 | 2.5 | · | 5.3 | 8.5 | 11.2 | · | 34.5 | |
| P/B | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Tangible Book | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Cash Flow | · | -7.3 | · | · | · | -7.0 | · | · | · | -2.9 | · | · | · | -8.3 | · | · | |
| P / FCF | · | -7.3 | · | · | · | -6.7 | · | · | · | -2.8 | · | · | · | -7.8 | · | · | |
| Earnings Yield | -33.6% | 14.2% | · | 18.4% | 3.7% | 8.4% | · | -110.7% | -170.6% | -107.7% | · | -52.1% | -40.8% | -38.4% | · | -80.5% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $7M | $26M | $24M | $15M | $14M |
| Marge d'exploitation % | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% |
| Résultat net | $-21M | $-64M | $-66M | $-61M | $-110M |
| BPA dilué | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 |
| Ratio de liquidité réduite | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-98M | $-61M | $-64M | $-50M | $-22M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 84 déclarants · $187.5M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 32 (+13 vs T. préc.) | 11 (+7 vs T. préc.) | 25 (+11 vs T. préc.) | 12 (+4 vs T. préc.) | +8.5M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| Yu Fan | $22 264 818 | 4 861 314 | 11,87% | Actions |
| ACUTA CAPITAL PARTNERS, LLC | $21 461 477 | 4 685 912 | 11,44% | Actions |
| QVT Financial LP | $21 139 947 | 4 615 709 | 11,27% | Actions |
| MONTANOVA CAPITAL, LLC | $19 694 000 | 4 300 000 | 10,50% | Actions |
| ORBIMED ADVISORS LLC | $18 019 076 | 3 934 296 | 9,61% | Actions |
| Avoro Capital Advisors LLC | $13 050 261 | 2 849 402 | 6,96% | Actions |
| Siren, L.L.C. | $10 703 927 | 2 337 102 | 5,71% | Actions |
| KVP Capital Advisors, LP | $9 920 266 | 2 165 997 | 5,29% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $6 359 609 | 1 388 561 | 3,39% | Actions |
| ADAR1 Capital Management, LLC | $6 143 585 | 1 341 394 | 3,28% | Actions |
| ACORN CAPITAL ADVISORS, LLC | $5 218 283 | 1 139 363 | 2,78% | Actions |
| STEMPOINT CAPITAL LP | $4 676 349 | 1 021 037 | 2,49% | Actions |
| Ally Bridge Group (NY) LLC | $3 746 161 | 817 939 | 2,00% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $3 495 462 | 762 997 | 1,86% | Actions |
| Woodline Partners LP | $1 999 692 | 436 614 | 1,07% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $1 895 305 | 413 822 | 1,01% | Actions |
| STATE STREET CORP | $1 772 378 | 386 982 | 0,95% | Actions |
| MILLENNIUM MANAGEMENT LLC | $1 742 259 | 380 406 | 0,93% | Actions |
| Eversept Partners, LP | $1 389 141 | 303 306 | 0,74% | Actions |
| Verdad Advisers, LP | $1 380 792 | 301 483 | 0,74% | Actions |
| TWO SIGMA INVESTMENTS, LP | $1 358 483 | 296 612 | 0,72% | Actions |
| AMES NATIONAL CORP | $1 333 269 | 4 571 | 0,71% | Actions |
| Balyasny Asset Management L.P. | $1 319 576 | 288 117 | 0,70% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $1 130 834 | 246 907 | 0,60% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 004 014 | 219 217 | 0,54% | Actions |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $757 001 | 165 284 | 0,40% | Actions |
| VANGUARD GROUP INC | $519 881 | 214 827 | 0,28% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $361 051 | 78 832 | 0,19% | Actions |
| GOLDMAN SACHS GROUP INC | $349 060 | 76 214 | 0,19% | Actions |
| Point72 Asset Management, L.P. | $261 651 | 57 129 | 0,14% | Actions |
| AMERICAN CENTURY COMPANIES INC | $237 427 | 51 840 | 0,13% | Actions |
| Qube Research & Technologies Ltd | $224 388 | 48 993 | 0,12% | Actions |
| UBS Group AG | $210 098 | 45 873 | 0,11% | Actions |
| Nuveen, LLC | $200 599 | 43 799 | 0,11% | Actions |
| Jump Financial, LLC | $186 864 | 40 800 | 0,10% | Actions |
| DEUTSCHE BANK AG\ | $145 039 | 31 668 | 0,08% | Actions |
| Bank of New York Mellon Corp | $132 623 | 28 957 | 0,07% | Actions |
| WELLS FARGO & COMPANY/MN | $124 457 | 27 174 | 0,07% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $123 761 | 27 022 | 0,07% | Actions |
| RHUMBLINE ADVISERS | $112 338 | 24 529 | 0,06% | Actions |
| Y-Intercept (Hong Kong) Ltd | $111 583 | 24 363 | 0,06% | Actions |
| TWO SIGMA ADVISERS, LP | $102 608 | 42 400 | 0,05% | Actions |
| Vanguard Global Advisers, LLC | $89 205 | 19 477 | 0,05% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $85 646 | 18 700 | 0,05% | Actions |
| BANK OF AMERICA CORP /DE/ | $85 518 | 18 672 | 0,05% | Actions |
| XTX Topco Ltd | $84 831 | 18 522 | 0,05% | Actions |
| CITADEL ADVISORS LLC | $79 440 | 17 345 | 0,04% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $68 434 | 14 942 | 0,04% | Actions |
| ABG Innovation Capital Partners III GP Ltd | $64 532 | 26 666 | 0,03% | Actions |
| CITIGROUP INC | $60 209 | 13 146 | 0,03% | Actions |
| JPMORGAN CHASE & CO | $59 323 | 13 452 | 0,03% | Actions |
| Invesco Ltd. | $59 261 | 12 939 | 0,03% | Actions |
| EVERGREEN CAPITAL MANAGEMENT LLC | $50 380 | 11 000 | 0,03% | Actions |
| Scientech Research LLC | $49 638 | 10 838 | 0,03% | Actions |
| Police & Firemen's Retirement System of New Jersey | $46 739 | 10 205 | 0,02% | Actions |
| Quadrature Capital Ltd | $46 002 | 10 044 | 0,02% | Actions |
| TWO SIGMA SECURITIES, LLC | $45 951 | 10 033 | 0,02% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $31 804 | 6 944 | 0,02% | Actions |
| NORTHERN TRUST CORP | $23 239 | 5 074 | 0,01% | Actions |
| BARCLAYS PLC | $22 182 | 4 843 | 0,01% | Actions |
| US BANCORP \DE\ | $15 265 | 3 333 | 0,01% | Actions |
| Legal & General Group Plc | $14 482 | 3 162 | 0,01% | Actions |
| Ameritas Investment Partners, Inc. | $13 488 | 2 945 | 0,01% | Actions |
| Russell Investments Group, Ltd. | $11 880 | 2 594 | 0,01% | Actions |
| Tower Research Capital LLC (TRC) | $11 702 | 2 555 | 0,01% | Actions |
| BlackRock, Inc. | $11 601 | 2 533 | 0,01% | Actions |
| OSAIC HOLDINGS, INC. | $7 048 | 1 539 | 0,00% | Actions |
| BARTLETT & CO. WEALTH MANAGEMENT LLC | $6 105 | 1 333 | 0,00% | Actions |
| ROYAL BANK OF CANADA | $5 000 | 1 114 | 0,00% | Actions |
| MORGAN STANLEY | $3 490 | 762 | 0,00% | Actions |
| Sterling Capital Management LLC | $2 995 | 654 | 0,00% | Actions |
| SATTER MANAGEMENT CO., L.P. | $2 079 | 659 | 0,00% | Actions |
| SBI Securities Co., Ltd. | $1 452 | 317 | 0,00% | Actions |
| Quarry LP | $998 | 218 | 0,00% | Actions |
| TD Waterhouse Canada Inc. | $993 | 232 | 0,00% | Actions |
| FMR LLC | $779 | 170 | 0,00% | Actions |
| ACADIAN ASSET MANAGEMENT LLC | $778 | 170 883 | 0,00% | Actions |
| Caitong International Asset Management Co., Ltd | $664 | 145 | 0,00% | Actions |
| Integrated Wealth Concepts LLC | $604 | 132 | 0,00% | Actions |
| PRICE T ROWE ASSOCIATES INC /MD/ | $122 | 26 609 | 0,00% | Actions |
| CWM, LLC | $86 | 25 | 0,00% | Actions |
| SIMPLEX TRADING, LLC | $82 | 18 | 0,00% | Actions |
| Virtu Financial LLC | $66 | 14 479 | 0,00% | Actions |
| Parallel Advisors, LLC | $37 | 8 | 0,00% | Actions |
Initiés de la société 24 initiés · 9 dirigeants · 16 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| David James Lennon | Chief Executive Officer | 2 octobre 2023 A | — | 0 | 0 | $0 |
| Scott M. Giacobello | CFO, Interim CEO & President | 3 avril 2023 A | 20 000 | 0 | 0 | $0 |
| Brendan Delaney | President and Chief Executive Officer | 1 mars 2023 A | 20 000 | 0 | 0 | $0 |
| Stephen J Hoffman | Chief Executive Officer | 14 mai 2019 A | 31 967 | 0 | 0 | $0 |
| Joseph H. Gardner | President | 16 mars 2020 A | 453 019 | 0 | 0 | $0 |
| Lorettta M Itri | Chief Medical Officer | 1 mars 2023 A | — | 0 | 0 | $0 |
| Kevin G. Peters | Chief Scientific Officer and Acting Chief Medical Officer Exhibit 24: Power of Attorney | 16 mars 2020 A | 320 536 | 0 | 0 | $0 |
| Michael W Rogers | Chief Financial and Chief Business Officer | 14 mai 2019 A | — | 0 | 0 | $0 |
| Steve Pakola | Chief Medical Officer | 15 février 2019 A | — | 0 | 0 | $0 |
| Baiteng Zhao | Administrateur | 12 juin 2026 A | — | 0 | 0 | $0 |
| Neil Desai | Administrateur | 12 juin 2026 A | 1 453 543 | 0 | 0 | $0 |
| Emma Reeve | Administrateur | 12 juin 2026 A | — | 0 | 0 | $0 |
| Mohammad Hirmand | Administrateur | 12 juin 2026 A | — | 0 | 0 | $0 |
| Anupam Dalal | Administrateur | 12 juin 2026 A | 4 685 912 | 0 | 0 | $0 |
| Richard E Maroun | Administrateur | 12 juin 2026 A | — | 0 | 0 | $0 |
| Caley Castelein | Administrateur | 12 juin 2026 A | 274 796 | 0 | 0 | $0 |
| Karin M. Hehenberger | Administrateur | 15 juin 2023 A | — | 0 | 0 | $0 |
| Cheryl Cohen | Administrateur | 17 juin 2021 A | 8 020 | 0 | 0 | $0 |
| Chau Quang Khuong | Administrateur | 18 juin 2019 A | 5 193 946 | 0 | 0 | $0 |
| Satter Muneer A | Administrateur | 18 juin 2019 A | 5 621 835 | 0 | 0 | $0 |
| Paul M Weiss | Administrateur | 15 mars 2017 P | 1 576 167 | 0 | 0 | $0 |
| Dugel Pravin | — | 30 juin 2021 A | 12 568 | 0 | 0 | $0 |
| Steven Prelack | — | 30 juin 2021 A | 24 485 | 0 | 0 | $0 |
| Regina Marek | — | 16 mars 2020 A | — | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 13 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC, ANUPAM DALAL, Acuta Capital Fund, LP ×3 dépôts | 18 mai 2026 | 9,00% | Amendement | Investissement passif | SEC |
| Avoro Capital Advisors LLC, Avoro Ventures LLC, Behzad Aghazadeh ×6 dépôts | 14 mai 2026 | 19,99% | Amendement | — | SEC |
| Neil Desai ×5 dépôts | 6 mars 2025 | 4,90% | Amendement | — | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael ×5 dépôts | 5 mars 2025 | 4,98% | Amendement | — | SEC |
| Muneer A. Satter (2) ×5 dépôts | 12 novembre 2021 | — | Dépôt initial | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP V LLC ×4 dépôts | 3 septembre 2021 | — | Dépôt initial | — | SEC |
| Novartis Bioventures Ltd., Novartis AG ×7 dépôts | 15 mai 2020 | — | Dépôt initial | — | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 dépôts | 4 octobre 2018 | — | Dépôt initial | — | SEC |
| Venture Investors Early Stage Fund IV Limited Partnership (2), VIESF IV GP LLC (2) | 27 mars 2017 | — | Dépôt initial | — | SEC |
| Novartis Bioventures Ltd. (2), Novartis AG (2) | 27 mars 2017 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 4 avril 2008 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 4 avril 2008 | — | Dépôt initial | — | SEC |
| Argyris Vassiliou | 4 avril 2008 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 10 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 23 692 SH | 8 août 2026 | Quotidien |
| IWC · iShares Trust | 0,03% | 110 575 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 28 211 SH | 8 août 2026 | Quotidien |
| IWN · iShares Trust | 0,01% | 278 917 SH | 8 août 2026 | Quotidien |
| IWM · iShares Trust | 0,00% | 719 241 SH | 8 août 2026 | Quotidien |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 20 759 NS | 31 mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 470 854 SH | 8 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 887 972 SH | 8 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 187 597 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 409 SH | 8 août 2026 | Quotidien |